Skip to main navigation Skip to search Skip to main content

Age-Related Brain Atrophy and the Positive Effects of Behavioral Enrichment in Middle-Aged Beagles

  • Jessica A. Noche
  • , Hamsanandini Radhakrishnan
  • , Margo F. Ubele
  • , Kathy Boaz
  • , Jennifer L. Mefford
  • , Erin D. Jones
  • , Hollie Y. van Rooyen
  • , Jessica A. Perpich
  • , Katie McCarty
  • , Beverly Meacham
  • , Jeffrey Smiley
  • , Stasia A. Bembenek Bailey
  • , László G. Puskás
  • , David K. Powell
  • , Lorena Sordo
  • , Michael J. Phelan
  • , Christopher M. Norris
  • , Elizabeth Head
  • , Craig E.L. Stark

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Aging dogs serve as a valuable preclinical model for Alzheimer’s disease (AD) due to their natural age-related development of β-amyloid (Aβ) plaques, human-like metabolism, and large brains that are ideal for studying structural brain aging trajectories from serial neuroimaging. Here we examined the effects of chronic treatment with the calcineurin inhibitor (CNI) tacrolimus or the nuclear factor of activated T cells (NFAT)-inhibiting compound Q134R on age-related canine brain atrophy from a longitudinal study in middle-aged beagles (36 females, 7 males) undergoing behavioral enrichment. Annual MRI was analyzed using modern, automated techniques for region-of-interest-based and voxel-based volumetric assessments. We found that the frontal lobe showed accelerated atrophy with age, while the caudate nucleus remained relatively stable. Remarkably, the hippocampus increased in volume in all dogs. None of these changes were influenced by tacrolimus or Q134R treatment. Our results suggest that behavioral enrichment can prevent atrophy and increase the volume of the hippocampus but does not prevent aging-associated prefrontal cortex atrophy.

Original languageEnglish
Article numbere2366232024
JournalJournal of Neuroscience
Volume44
Issue number20
DOIs
StatePublished - May 15 2024

Bibliographical note

Publisher Copyright:
© 2024 the authors.

Funding

The study was supported by National Institutes of Health/National Institute on Aging (NIH/NIA) R01AG056998 (EH/CN/CELS). J.A.N. is supported by NIH/NIA T32AG073088. We thank Christine Lee and Elena Singh for their assistance in quality control of the imaging data. Received Dec. 15, 2023; revised Feb. 8, 2024; accepted Feb. 28, 2024. Author contributions: J.A.N., H.R., M.J.P., and C.E.L.S. analyzed data; M.F.U., K.B., J.L.M., E.D.J., J.A.P., K.M., B.M., J.S., S.A.B.B., D.K.P., and L.S. performed research; L.G.P., C.M.N., and E.H. designed research; E.H. and C.E.L.S. contributed unpublished reagents/analytic tools; J.A.N. wrote the paper. The study was supported by National Institutes of Health/National Institute on Aging (NIH/NIA) R01AG056998 (EH/CN/CELS). J.A.N. is supported by NIH/NIA T32AG073088. We thank Christine Lee and Elena Singh for their assistance in quality control of the imaging data. L.G.P.: personal financial interests, as he is the main shareholder of one of Aperus Pharma’s company shares. Correspondence should be addressed to Jessica A. Noche at [email protected]. https://doi.org/10.1523/JNEUROSCI.2366-23.2024 Copyright © 2024 the authors

FundersFunder number
National Institutes of Health (NIH)
National Institute on AgingR01AG056998, T32AG073088
National Institute on Aging

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Alzheimer’s disease
    • Q134R
    • amyloid
    • beagle
    • calcineurin
    • neurodegeneration
    • prevention
    • tacrolimus

    ASJC Scopus subject areas

    • General Neuroscience

    Fingerprint

    Dive into the research topics of 'Age-Related Brain Atrophy and the Positive Effects of Behavioral Enrichment in Middle-Aged Beagles'. Together they form a unique fingerprint.

    Cite this